| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1840f46140e982892d0680256b2fd1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51dd263bf7bdfe9fcae7819d2d88adba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f56e9cf38f41faad89750debd485465 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-02 |
| filingDate |
2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502cde6e7908f915d7c2eb4dc1a0338b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925c5ad6875d5bd4a148277598c85ae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fe621faa7674565036882889ae8088c |
| publicationDate |
2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009198053-A1 |
| titleOfInvention |
Pyrazine Derivatives and Uses Thereof in Renal Monitoring |
| abstract |
The present invention relates to pyrazine derivatives such as those represented by Formulas (I) and (II) below. X 1 to X 4 of the compounds of Formulas I and II may be characterized as electron withdrawing groups. In contrast, Y 1 to Y 4 of the compounds of Formulas I and II may be characterized as electron donating groups. Pyrazine derivatives of the present invention may be utilized in assessing renal function. In particular, an effective amount of a pyrazine derivative of the invention may be administered into a body of a patient. The pyrazine derivative that is in the body may be exposed to visible and/or infrared light to cause spectral energy to emanate from the pyrazine derivative. This emanating spectral energy may be detected and utilized to determine renal function of the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9433700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015070256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110494167-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3733183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019084475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10967096-B2 |
| priorityDate |
2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |